Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Ticker SymbolMRK
Company nameMerck & Co Inc
IPO dateFeb 06, 2077
CEODavis (Robert M)
Number of employees75000
Security typeOrdinary Share
Fiscal year-endFeb 06
Address126 East Lincoln Avenue
CityRAHWAY
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07065
Phone19087404000
Websitehttps://www.merck.com/
Ticker SymbolMRK
IPO dateFeb 06, 2077
CEODavis (Robert M)